Case report of congenital myotonic dystrophy with multiple prenatal sonographic findings
Author:
Strelcovienė Zita1, Machtejevienė Eglė1, Minkauskienė Meilė1, Traberg Rasa2
Affiliation:
1. Medical Academy, Department of Obstetrics and Gynaecology , 230647 Lithuanian University of Health Sciences , Kaunas , Lithuania 2. Medical Academy, Department of Genetics and Molecular Medicine , 230647 Lithuanian University of Health Sciences , Kaunas , Lithuania
Abstract
Abstract
Objectives
Myotonic dystrophy 1 (DM1) is an autosomal dominant inherited neuromuscular disorder. The most severe form is congenital myotonic dystrophy (cDM). Prenatal diagnosis is complicated and sonographic findings of cDM that are not pathognomonic occur in the late second or early third trimester of pregnancy.
Case presentation
It is the case of prenatally diagnosed cDM. In 32 weeks of pregnancy multiple sonographic findings such as severe polyhydramnios, bilateral talipes, fetal legs akinesia, macrocephaly with mild bilateral ventriculomegaly, right-sided pleural effusion and diaphragmatic pathology were observed by fetal medicine specialist. As the patient complained of weakness in her limbs, she was consulted by a neurologist. The neurological examination revealed a pathognomonic sign of DM1 – grip myotonia. The amniotic fluid and the mother’s blood sample were further tested for DM1. This identified >150 repeats in one copy of the DMPK gene of the both, which is consistent with the diagnosis DM1.
Conclusions
The sonographic findings of fetal limb abnormalities with progressive polyhydramnios is an indication for maternal neurological examination and genetic testing due to myotonic dystrophy.
Publisher
Walter de Gruyter GmbH
Reference22 articles.
1. Siciliano, G, Manca, M, Gennarelli, M, Angelini, C, Rocchi, A, Iudice, A, et al.. Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis. Clin Genet 2001;59:344–9. https://doi.org/10.1034/j.1399-0004.2001.590508.x. 2. Norwood, FL, Harling, C, Chinnery, PF, Eagle, M, Bushby, K, Straub, V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 2009;132:3175–86. https://doi.org/10.1093/brain/awp236. 3. Johnson, NE, Butterfield, RJ, Mayne, K, Newcomb, T, Imburgia, C, Dunn, D, et al.. Population-based prevalence of myotonic dystrophy type 1 using genetic analysis of statewide blood screening program. Neurology 2021;96:e1045–53. https://doi.org/10.1212/wnl.0000000000011425. 4. Brook, JD, McCurrach, ME, Harley, HG, Buckler, AJ, Church, D, Aburatani, H, et al.. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799–808. https://doi.org/10.1016/0092-8674(92)90154-5. 5. Jain, A, Al Khalili, Y. Congenital myotonic dystrophy. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2023 [Accessed 2 Feb 2023].
|
|